PL3574895T3 - Zmniejszanie wielkości cząstek związku przeciwmuskarynowego - Google Patents
Zmniejszanie wielkości cząstek związku przeciwmuskarynowegoInfo
- Publication number
- PL3574895T3 PL3574895T3 PL19182996.9T PL19182996T PL3574895T3 PL 3574895 T3 PL3574895 T3 PL 3574895T3 PL 19182996 T PL19182996 T PL 19182996T PL 3574895 T3 PL3574895 T3 PL 3574895T3
- Authority
- PL
- Poland
- Prior art keywords
- particle size
- size reduction
- antimuscarinic compound
- antimuscarinic
- compound
- Prior art date
Links
- 230000001022 anti-muscarinic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000010951 particle size reduction Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13165483 | 2013-04-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3574895T3 true PL3574895T3 (pl) | 2023-06-19 |
Family
ID=48190260
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19182996.9T PL3574895T3 (pl) | 2013-04-26 | 2014-04-24 | Zmniejszanie wielkości cząstek związku przeciwmuskarynowego |
| PL14724332T PL2988728T3 (pl) | 2013-04-26 | 2014-04-24 | Zmniejszanie wielkości cząstek związku przeciwmuskarynowego |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14724332T PL2988728T3 (pl) | 2013-04-26 | 2014-04-24 | Zmniejszanie wielkości cząstek związku przeciwmuskarynowego |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US9393202B2 (pl) |
| EP (2) | EP3574895B1 (pl) |
| JP (1) | JP6449246B2 (pl) |
| KR (1) | KR102198354B1 (pl) |
| CN (1) | CN105120841B (pl) |
| AR (1) | AR096087A1 (pl) |
| AU (1) | AU2014259443B2 (pl) |
| BR (1) | BR112015024626B1 (pl) |
| CA (1) | CA2910314C (pl) |
| DK (2) | DK3574895T3 (pl) |
| ES (2) | ES2943109T3 (pl) |
| FI (1) | FI3574895T3 (pl) |
| HK (1) | HK1216302A1 (pl) |
| HR (2) | HRP20230337T1 (pl) |
| HU (2) | HUE062002T2 (pl) |
| IL (1) | IL242209A (pl) |
| MX (1) | MX365295B (pl) |
| MY (1) | MY169127A (pl) |
| PH (1) | PH12015502449B1 (pl) |
| PL (2) | PL3574895T3 (pl) |
| PT (2) | PT2988728T (pl) |
| RU (1) | RU2667636C2 (pl) |
| SG (1) | SG11201508760VA (pl) |
| SI (2) | SI2988728T1 (pl) |
| TW (1) | TWI630926B (pl) |
| UA (1) | UA120418C2 (pl) |
| WO (1) | WO2014173987A1 (pl) |
| ZA (1) | ZA201507916B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9393202B2 (en) * | 2013-04-26 | 2016-07-19 | Chiesi Farmaceutici S.P.A | Particle size reduction of an antimuscarinic compound |
| KR20160029797A (ko) | 2013-07-11 | 2016-03-15 | 키에시 파르마슈티시 엣스. 피. 에이. | 흡입에 의한 투여를 위한 항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제 |
| KR20170070151A (ko) | 2014-10-16 | 2017-06-21 | 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 | 흡입형 제제 |
| JP6500522B2 (ja) * | 2015-03-16 | 2019-04-17 | セイコーエプソン株式会社 | 回路装置、物理量検出装置、電子機器及び移動体 |
| HUE050343T2 (hu) | 2015-11-16 | 2020-11-30 | Chiesi Farm Spa | Eljárás antikolinerg szert, kortikoszteroidot és béta-adrenerg szert tartalmazó száraz porkészítmény elõállítására |
| SI3628331T1 (sl) | 2015-11-16 | 2021-11-30 | Chiesi Farmaceutici S.P.A. | Postopek za pripravo suhe praškaste formulacije, ki obsega antiholinergik, kortikosteroid in beta-adrenergik |
| US9925168B2 (en) * | 2016-01-22 | 2018-03-27 | Chiesi Farmaceutici S.P.A. | Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation |
| JP6323846B2 (ja) * | 2016-04-07 | 2018-05-16 | 塩野義製薬株式会社 | オピオイドを含有する乱用防止製剤 |
| PT109445B (pt) * | 2016-06-08 | 2018-11-06 | Hovione Farm Sa | Co-cristais farmacêuticos cristalinos de brometo de glicopirrónio com lactose |
| ES2805434T3 (es) * | 2016-07-29 | 2021-02-12 | Inke Sa | Procedimiento de estabilización de tamaño de partícula |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| HUT70952A (en) * | 1992-06-10 | 1995-11-28 | Eastman Kodak Co | Surface modified nanoparticles based on nosteroidal inflammatory drugs, process for preparing them and pharmaceutical compns. contg. them |
| GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| CN1713893A (zh) * | 2002-11-18 | 2005-12-28 | 纳幕尔杜邦公司 | 采用非球形研磨介质的介质研磨 |
| GB0321607D0 (en) | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| GB0409703D0 (en) * | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
| GB0516549D0 (en) | 2005-08-12 | 2005-09-21 | Sulaiman Brian | Milling system |
| GB0613161D0 (en) * | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
| KR20100095587A (ko) * | 2007-12-13 | 2010-08-31 | 노파르티스 아게 | 유기 화합물 |
| KR20100099281A (ko) * | 2007-12-13 | 2010-09-10 | 노파르티스 아게 | 유기 화합물 |
| DE102008000482A1 (de) | 2008-03-03 | 2009-09-10 | Zf Friedrichshafen Ag | Ölgekühltes Reibschaltelement |
| ES2611031T3 (es) * | 2008-07-18 | 2017-05-04 | Prosonix Limited | Proceso de mejora de la cristalinidad |
| PL3106149T3 (pl) * | 2009-05-29 | 2020-06-01 | Pearl Therapeutics, Inc. | Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy |
| US20150093440A1 (en) * | 2010-10-15 | 2015-04-02 | Glaxo Group Limited | Aggregate nanoparticulate medicament formulations, manufacture and use thereof |
| US9393202B2 (en) * | 2013-04-26 | 2016-07-19 | Chiesi Farmaceutici S.P.A | Particle size reduction of an antimuscarinic compound |
-
2014
- 2014-04-22 US US14/258,147 patent/US9393202B2/en active Active
- 2014-04-24 MX MX2015014904A patent/MX365295B/es active IP Right Grant
- 2014-04-24 CA CA2910314A patent/CA2910314C/en active Active
- 2014-04-24 UA UAA201510382A patent/UA120418C2/uk unknown
- 2014-04-24 SG SG11201508760VA patent/SG11201508760VA/en unknown
- 2014-04-24 JP JP2016509457A patent/JP6449246B2/ja active Active
- 2014-04-24 HR HRP20230337TT patent/HRP20230337T1/hr unknown
- 2014-04-24 BR BR112015024626-5A patent/BR112015024626B1/pt active IP Right Grant
- 2014-04-24 PT PT147243323T patent/PT2988728T/pt unknown
- 2014-04-24 ES ES19182996T patent/ES2943109T3/es active Active
- 2014-04-24 AU AU2014259443A patent/AU2014259443B2/en active Active
- 2014-04-24 AR ARP140101710A patent/AR096087A1/es not_active Application Discontinuation
- 2014-04-24 EP EP19182996.9A patent/EP3574895B1/en active Active
- 2014-04-24 PL PL19182996.9T patent/PL3574895T3/pl unknown
- 2014-04-24 SI SI201431365T patent/SI2988728T1/sl unknown
- 2014-04-24 DK DK19182996.9T patent/DK3574895T3/da active
- 2014-04-24 FI FIEP19182996.9T patent/FI3574895T3/fi active
- 2014-04-24 RU RU2015145521A patent/RU2667636C2/ru active
- 2014-04-24 PL PL14724332T patent/PL2988728T3/pl unknown
- 2014-04-24 ES ES14724332T patent/ES2754255T3/es active Active
- 2014-04-24 HU HUE19182996A patent/HUE062002T2/hu unknown
- 2014-04-24 WO PCT/EP2014/058295 patent/WO2014173987A1/en active Application Filing
- 2014-04-24 MY MYPI2015002624A patent/MY169127A/en unknown
- 2014-04-24 EP EP14724332.3A patent/EP2988728B1/en active Active
- 2014-04-24 TW TW103114823A patent/TWI630926B/zh active
- 2014-04-24 SI SI201432023T patent/SI3574895T1/sl unknown
- 2014-04-24 KR KR1020157026634A patent/KR102198354B1/ko active IP Right Grant
- 2014-04-24 HU HUE14724332A patent/HUE046213T2/hu unknown
- 2014-04-24 PT PT191829969T patent/PT3574895T/pt unknown
- 2014-04-24 DK DK14724332T patent/DK2988728T3/da active
- 2014-04-24 CN CN201480022369.0A patent/CN105120841B/zh active Active
-
2015
- 2015-10-22 IL IL242209A patent/IL242209A/en active IP Right Grant
- 2015-10-23 ZA ZA2015/07916A patent/ZA201507916B/en unknown
- 2015-10-23 PH PH12015502449A patent/PH12015502449B1/en unknown
-
2016
- 2016-06-08 HK HK16104300.9A patent/HK1216302A1/zh unknown
- 2016-06-10 US US15/179,048 patent/US9889094B2/en active Active
-
2019
- 2019-10-17 HR HRP20191882TT patent/HRP20191882T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276456B (en) | Tetrahydroquinoline preparations as bromodomain bet inhibitors | |
| IL249517A0 (en) | A compound that inhibits trk | |
| HK1216302A1 (zh) | 抗毒蕈鹼化合物的粒度減小 | |
| GB201302368D0 (en) | Compound | |
| HK1219100A1 (zh) | 吡啶基吡唑並喹啉化合物 | |
| EP2947066A4 (en) | PHENOXYALKYLAMINVERBINDUNG | |
| GB201307295D0 (en) | Brake shield | |
| IL241070A0 (en) | Powder particles with additional coating | |
| EP3010982A4 (en) | ENCAPSULATION OF SOLID PARTICLES | |
| GB201307331D0 (en) | Compound | |
| HK1208689A1 (en) | Particle size reduction | |
| GB201408643D0 (en) | Compound | |
| GB2513424B (en) | Apparatus for reducing particle size | |
| PL2948131T3 (pl) | Formowanie struktur cząstkowych | |
| GB201322438D0 (en) | Compound | |
| GB201315772D0 (en) | Compound | |
| GB201305634D0 (en) | Compound | |
| GB201304250D0 (en) | Compound | |
| GB201301585D0 (en) | Compound |